193 related articles for article (PubMed ID: 20434359)
1. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
Hager-Braun C; Hochleitner EO; Gorny MK; Zolla-Pazner S; Bienstock RJ; Tomer KB
J Am Soc Mass Spectrom; 2010 Oct; 21(10):1687-98. PubMed ID: 20434359
[TBL] [Abstract][Full Text] [Related]
2. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
Nakamura GR; Byrn R; Wilkes DM; Fox JA; Hobbs MR; Hastings R; Wessling HC; Norcross MA; Fendly BM; Berman PW
J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis.
Hager-Braun C; Tomer KB
Biochemistry; 2002 Feb; 41(6):1759-66. PubMed ID: 11827520
[TBL] [Abstract][Full Text] [Related]
4. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites.
Pinter A; Honnen WJ; Tilley SA
J Virol; 1993 Sep; 67(9):5692-7. PubMed ID: 7688827
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120.
McKeating JA; Shotton C; Cordell J; Graham S; Balfe P; Sullivan N; Charles M; Page M; Bolmstedt A; Olofsson S
J Virol; 1993 Aug; 67(8):4932-44. PubMed ID: 7687306
[TBL] [Abstract][Full Text] [Related]
6. Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18.
Gift SK; Zentner IJ; Schön A; McFadden K; Umashankara M; Rajagopal S; Contarino M; Duffy C; Courter JR; Zhang MY; Gershoni JM; Cocklin S; Dimitrov DS; Smith AB; Freire E; Chaiken IM
Biochemistry; 2011 Apr; 50(14):2756-68. PubMed ID: 21351734
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
[TBL] [Abstract][Full Text] [Related]
8. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
[TBL] [Abstract][Full Text] [Related]
9. PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.
Falkowska E; Ramos A; Feng Y; Zhou T; Moquin S; Walker LM; Wu X; Seaman MS; Wrin T; Kwong PD; Wyatt RT; Mascola JR; Poignard P; Burton DR
J Virol; 2012 Apr; 86(8):4394-403. PubMed ID: 22345481
[TBL] [Abstract][Full Text] [Related]
10. Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Zhou T; Xu L; Dey B; Hessell AJ; Van Ryk D; Xiang SH; Yang X; Zhang MY; Zwick MB; Arthos J; Burton DR; Dimitrov DS; Sodroski J; Wyatt R; Nabel GJ; Kwong PD
Nature; 2007 Feb; 445(7129):732-7. PubMed ID: 17301785
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120.
Ferrer M; Sullivan BJ; Godbout KL; Burke E; Stump HS; Godoy J; Golden A; Profy AT; van Schravendijk MR
J Pept Res; 1999 Jul; 54(1):32-42. PubMed ID: 10448968
[TBL] [Abstract][Full Text] [Related]
12. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding.
Stamatatos L; Cheng-Mayer C
J Virol; 1995 Oct; 69(10):6191-8. PubMed ID: 7545244
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A.
Hochleitner EO; Gorny MK; Zolla-Pazner S; Tomer KB
J Immunol; 2000 Apr; 164(8):4156-61. PubMed ID: 10754311
[TBL] [Abstract][Full Text] [Related]
14. Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding.
Choe HR; Sodroski J
J Acquir Immune Defic Syndr (1988); 1992; 5(2):204-10. PubMed ID: 1732513
[TBL] [Abstract][Full Text] [Related]
15. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction.
McKeating JA; Thali M; Furman C; Karwowska S; Gorny MK; Cordell J; Zolla-Pazner S; Sodroski J; Weiss RA
Virology; 1992 Sep; 190(1):134-42. PubMed ID: 1382339
[TBL] [Abstract][Full Text] [Related]
16. A rationally designed synthetic mimic of the discontinuous CD4-binding site of HIV-1 gp120.
Franke R; Hirsch T; Eichler J
J Recept Signal Transduct Res; 2006; 26(5-6):453-60. PubMed ID: 17118792
[TBL] [Abstract][Full Text] [Related]
17. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion.
Truneh A; Buck D; Cassatt DR; Juszczak R; Kassis S; Ryu SE; Healey D; Sweet R; Sattentau Q
J Biol Chem; 1991 Mar; 266(9):5942-8. PubMed ID: 1706342
[TBL] [Abstract][Full Text] [Related]
18. Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.
Sterjovski J; Churchill MJ; Ellett A; Wesselingh SL; Ramsland PA; Gorry PR
Virology; 2012 Oct; 432(2):394-404. PubMed ID: 22818780
[TBL] [Abstract][Full Text] [Related]
19. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
[TBL] [Abstract][Full Text] [Related]
20. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
Thali M; Moore JP; Furman C; Charles M; Ho DD; Robinson J; Sodroski J
J Virol; 1993 Jul; 67(7):3978-88. PubMed ID: 7685405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
